| 09/28/2012 |
|
Licensed to Sell? Quoting
IMDA Update
by Frank Fazio |
| |
|
|
| 08/14/2012 |
|
The Trend Towards Global Transparency: A Challenging New World for the Life Sciences Industry
Porzio, Bromberg & Newman P.C.
by D. Jeffrey Campbell and Brian P. Sharkey |
| |
|
|
| 06/22/2012 |
|
Pharmaceutical Sales Representatives Exempt From Overtime
Porzio Compliance Alert
by Kerri A. Wright |
| |
|
|
| 03/19/2012 |
|
Understanding the Sunshine Act: Dispersing the Clouds of Confusion
Porzio, Bromberg & Newman P.C.
by Christine N. Bradshaw and Sandra González |
| |
|
|
| 02/29/2012 |
|
Getting the Deal Through: Life Sciences 2012 - United States Chapter
Life Sciences in 25 Jurisdictions Worldwide
by John Patrick Oroho, Kenneth R. Meyer, and Brian P. Sharkey |
| |
|
|
| 02/13/2012 |
|
Are Pharma Sales Reps Entitled to Overtime Pay?
New Jersey Law Journal
by Kerri A. Wright |
| |
|
|
| 12/19/2011 |
|
CMS Publishes Draft Regulations to Implement the Sunshine Act
Porzio Compliance Alert
by Christine N. Bradshaw |
| |
|
|
| 05/01/2010 |
|
Taking Stock of the Marketing Retrictions and Prohibitions of Academic Medical Centers
FDLI Update
by D. Jeffrey Campbell and Christine N. Bradshaw |
| |
|
|
| 04/01/2010 |
|
Thriving Through Turmoil: Managing Sales and Marketing Regulation of the Medical Device Industry
FDLI Update
by D. Jeffrey Campbell and Jennifer A. Sanfilippo |
| |
|
|
| 02/01/2010 |
|
The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives
FDLI Update
by D. Jeffrey Campbell and Sarina D. Rivera |
| |
|
|
| 09/01/2009 |
|
Navigating Loss Reporting: How to Meet FDA and State Reporting Requirements
Thought Leadership Sales and Marketing Compliance
by Anne E. Wagstaff, John E. Niznik and Rhonda Sobral O'Toole |
| |
|
|
| 09/01/2009 |
|
What's All the Commotion Over Aggregate Spend?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Christine N. Bradshaw |
| |
|
|
| 06/01/2009 |
|
Court Prescribes No Overtime for Pharmaceutical Sales Rep
New Jersey Defense Quarterly
by Kerri A. Wright |
| |
|
|
| 05/28/2009 |
|
Sales Rep Nightmares: Emerging Issues in Marketing Compliance
FDLI Update
by John Patrick Oroho and Christine N. Bradshaw |
| |
|
|
| 03/09/2009 |
|
Over-the-Counter and Prescription Drug Manufacturers are Granted a One Year Reprieve from the Burdensome Requirements of the Consumer Product Safety Improvement Act
Porzio Pharmaceutical Alert
by Frank Fazio and Anne E. Wagstaff |
| |
|
|
| 02/01/2009 |
|
The End or Just the Beginning? Exploring Federal Preemption of State and Distribution Laws
Pharmaceutical Commerce
by Sarina D. Rivera, Jennifer A. Sanfilippo and Kiaema R. Reid |
| |
|
|
| 09/11/2009 |
|
DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Jennifer A. Romanski and Sarina D. Rivera |
| |
|
|
| 08/27/2008 |
|
Navigating Through the Disparities of State Marketing Tracking and Disclosure Laws
Thought Leadership Sales and Marketing Compliance
by Garineh S. Dovletian and Christopher R. Corallo |
| |
|
|
| 06/18/2007 |
|
Newly Enacted Nevada Statute Requires Adoption of a "Marketing Code of Conduct."
Porzio Pharmaceutical Alert
by Linda Pissott Reig, Christopher R. Corallo and John Patrick Oroho |
| |
|
|
| 06/01/2007 |
|
State Marketing Disclosure Laws - The Unintended Consequences
FDLI Update
by Sarina D. Rivera |
| |
|
|
| 05/30/2007 |
|
Online DTC: Marketing Push Meets Consumer Pull
Pharmaceutical Commerce
by John Patrick Oroho |
| |
|
|
| 05/21/2007 |
|
Can Prosecutors Use Data from Sample Distribution as Evidence of Off-Label Promotion?
Thought Leadership Sales and Marketing Compliance
by John Patrick Oroho and Scott S. Liebman |